Sign in
4

Changes in Ownership

EXAGEN INC. Filed Acc 0000899243-19-024017

Options or other derivatives

  • Chief Scientific Officer acquired 10,891 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Dervieux Thierry Chief Scientific Officer 2019-09-18 Grant or award · Stock Option (right to buy) +10,891 10,891 D
Loading xslF345X03/doc4.xml…